Active immunotherapy of pancreatic cancer with tumor cells genetically engineered to secrete multiple cytokines

This publication has 10 references indexed in Scilit:

• The role of IL-2 secreted from genetically modified tumor cells in the establishment of antitumor immunity.
  The Journal of Immunology, 1994
• Tumor-rejection antigens recognized by T lymphocytes
  Current Opinion in Immunology, 1993
• Immunotherapy Via Gene Therapy
  Journal of Immunotherapy, 1993
• Regression of bladder tumors in mice treated with interleukin 2 gene-modified tumor cells.
  The Journal of Experimental Medicine, 1993
• Antimetastatic vaccination of tumor-bearing mice with two types of IFN-gamma gene-inserted tumor cells.
  The Journal of Immunology, 1993
• Tumor Rejection After Direct Costimulation of CD8 ⁺ T Cells by B7-Transfected Melanoma Cells
  Science, 1993
• Cancer statistics, 1993
  CA: A Cancer Journal for Clinicians, 1993
• Treatment of Established Renal Cancer by Tumor Cells Engineered to Secrete Interleukin-4
  Science, 1991
• T cell recognition of transforming proteins encoded by mutated ras proto-oncogenes.
  The Journal of Immunology, 1991
• Interleukin 2 gene transfer into tumor cells abrogates tumorigenicity and induces protective immunity.
  The Journal of Experimental Medicine, 1990